OSI PHARMACEUTICALS INC
S-3/A, EX-23.1, 2000-06-21
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: OSI PHARMACEUTICALS INC, S-3/A, 2000-06-21
Next: FIRST CONNECTICUT CAPITAL CORP/NEW/, 10KSB, 2000-06-21



<PAGE>   1


                                                                    EXHIBIT 23.1

                         CONSENT OF INDEPENDENT AUDITORS


         The Board of Directors
         OSI Pharmaceuticals, Inc.

         We consent to the use of our report dated December 22, 1999,
incorporated herein by reference, and to the reference to our firm under the
heading "Experts" in the prospectus.


                                                           /s/   KPMG LLP


Melville, New York
June 20, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission